Creative Planning’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.86M Sell
26,847
-3,514
-12% -$1.15M 0.01% 858
2025
Q4
$10.6M Buy
30,361
+363
+1% +$123K 0.01% 593
2025
Q3
$9.69M Buy
29,998
+5,560
+23% +$1.73M 0.01% 574
2025
Q2
$9.51M Sell
24,438
-6,477
-21% -$2.61M 0.01% 525
2025
Q1
$13.4M Buy
30,915
+7,667
+33% +$3.08M 0.01% 405
2024
Q4
$8.58M Sell
23,248
-7,086
-23% -$2.97M 0.01% 502
2024
Q3
$15.8M Sell
30,334
-822
-3% -$439K 0.02% 326
2024
Q2
$16.9M Buy
31,156
+2,901
+10% +$1.53M 0.02% 296
2024
Q1
$14.7M Buy
28,255
+1,442
+5% +$717K 0.02% 316
2023
Q4
$12.6M Buy
26,813
+858
+3% +$397K 0.02% 333
2023
Q3
$11.3M Sell
25,955
-3,634
-12% -$1.65M 0.02% 333
2023
Q2
$13.1M Buy
29,589
+5,720
+24% +$2.64M 0.02% 294
2023
Q1
$11M Sell
23,869
-2,508
-10% -$1.19M 0.02% 314
2022
Q4
$13.5M Buy
26,377
+5,116
+24% +$2.6M 0.02% 270
2022
Q3
$9.66M Buy
21,261
+444
+2% +$212K 0.02% 314
2022
Q2
$10M Buy
20,817
+38
+0.2% +$18.8K 0.02% 321
2022
Q1
$10.2M Buy
20,779
+2,554
+14% +$1.17M 0.02% 316
2021
Q4
$8.45M Buy
18,225
+189
+1% +$79.5K 0.01% 319
2021
Q3
$6.72M Sell
18,036
-135
-0.7% -$51.3K 0.01% 342
2021
Q2
$6.94M Sell
18,171
-4,862
-21% -$1.86M 0.01% 331
2021
Q1
$8.27M Buy
23,033
+2,563
+13% +$824K 0.02% 308
2020
Q4
$6.57M Sell
20,470
-1,015
-5% -$311K 0.01% 327
2020
Q3
$5.77M Buy
21,485
+2,489
+13% +$670K 0.02% 291
2020
Q2
$5M Buy
18,996
+845
+5% +$225K 0.01% 286
2020
Q1
$4.12M Buy
18,151
+599
+3% +$163K 0.01% 284
2019
Q4
$5.3M Buy
17,552
+773
+5% +$213K 0.02% 287
2019
Q3
$4.03M Buy
16,779
+573
+4% +$157K 0.01% 322
2019
Q2
$4.57M Sell
16,206
-1,191
-7% -$325K 0.02% 310
2019
Q1
$4.99M Sell
17,397
-247
-1% -$71.4K 0.02% 277
2018
Q4
$4.63M Sell
17,644
-734
-4% -$202K 0.02% 258
2018
Q3
$5.04M Sell
18,378
-845
-4% -$219K 0.02% 270
2018
Q2
$4.58M Buy
19,223
+1,634
+9% +$378K 0.02% 269
2018
Q1
$3.86M Sell
17,589
-100
-0.6% -$23.5K 0.02% 309
2017
Q4
$3.98M Buy
17,689
+1,030
+6% +$219K 0.02% 290
2017
Q3
$3.16M Sell
16,659
-96
-0.6% -$18.3K 0.01% 331
2017
Q2
$3.15M Buy
16,755
+418
+3% +$75.1K 0.02% 312
2017
Q1
$2.7M Sell
16,337
-608
-4% -$96.7K 0.01% 339
2016
Q4
$2.44M Buy
16,945
+48
+0.3% +$6.43K 0.01% 352
2016
Q3
$2.12M Sell
16,897
-1,492
-8% -$193K 0.01% 362
2016
Q2
$2.42M Sell
18,389
-1,852
-9% -$253K 0.02% 299
2016
Q1
$2.81M Sell
20,241
-21
-0.1% -$2.81K 0.02% 251
2015
Q4
$2.83M Buy
20,262
+538
+3% +$74.1K 0.02% 242
2015
Q3
$2.76M Buy
19,724
+4,246
+27% +$638K 0.02% 240
2015
Q2
$2.54M Buy
15,478
+2,868
+23% +$458K 0.02% 249
2015
Q1
$1.95M Buy
12,610
+6,857
+119% +$976K 0.02% 283
2014
Q4
$723K Buy
5,753
+676
+13% +$83.5K 0.01% 552
2014
Q3
$607K Buy
5,077
+1,048
+26% +$120K 0.01% 578
2014
Q2
$434K Sell
4,029
-775
-16% -$79.9K 0.01% 698
2014
Q1
$478K Buy
4,804
+467
+11% +$42.2K 0.01% 637
2013
Q4
$401K Buy
4,337
+411
+10% +$36.5K 0.01% 586
2013
Q3
$328K Buy
3,926
+701
+22% +$60.1K 0.01% 565
2013
Q2
$264K Buy
+3,225
New +$241K 0.01% 595

Other funds holding ELV

Creative Planning's ELV Position: Q1 2026 in Review

Creative Planning reduced its Elevance Health (ELV) stake by 12% in Q1 2026, selling an estimated $1.15M and leaving 26,847 shares worth $7.86M. The position accounts for 0.01% of the portfolio, ranked #858.

Creative Planning first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.9M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Creative Planning held 26,847 shares of Elevance Health worth $7.86M as of Q1 2026.
  • Creative Planning sold 3,514 Elevance Health shares in Q1 2026, an estimated $1.15M.
  • Elevance Health made up 0.01% of Creative Planning's portfolio in Q1 2026, its #858 holding.
  • Creative Planning first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Creative Planning's Elevance Health position peaked at $16.9M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.